Correlation Between Cullinan Oncology and PepGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and PepGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and PepGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and PepGen, you can compare the effects of market volatilities on Cullinan Oncology and PepGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of PepGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and PepGen.

Diversification Opportunities for Cullinan Oncology and PepGen

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cullinan and PepGen is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and PepGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PepGen and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with PepGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PepGen has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and PepGen go up and down completely randomly.

Pair Corralation between Cullinan Oncology and PepGen

Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 0.65 times more return on investment than PepGen. However, Cullinan Oncology LLC is 1.53 times less risky than PepGen. It trades about 0.05 of its potential returns per unit of risk. PepGen is currently generating about 0.02 per unit of risk. If you would invest  869.00  in Cullinan Oncology LLC on August 25, 2024 and sell it today you would earn a total of  385.00  from holding Cullinan Oncology LLC or generate 44.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cullinan Oncology LLC  vs.  PepGen

 Performance 
       Timeline  
Cullinan Oncology LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
PepGen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PepGen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Cullinan Oncology and PepGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cullinan Oncology and PepGen

The main advantage of trading using opposite Cullinan Oncology and PepGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, PepGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PepGen will offset losses from the drop in PepGen's long position.
The idea behind Cullinan Oncology LLC and PepGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine